🇺🇸 FDA
Patent

US 10752690

Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10752690 (Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K47/6801, A61K47/68031